't zal maar gebeuren schreef op 16 februari 2017 10:22:
[...]
Revenue for Partner Products was SEK 203 M (193) in the quarter,
an increase of 5 per cent,
mainly due to continued growth for
Xiapex and to the partnership with PharmaSwissm.a.w. ruc. doet bij sobi geen ruk.